INTRODUCTION
During the late 1970s, several laboratories started working on the identification of proteoglycans and hyaluronate-binding proteins in the brain [1, 2] . Glial hyaluronate-binding protein (GHAP) is a 60 kDa glycoprotein expressed primarily in the extracellular matrix of the white matter [3] . Partial amino acid sequences indicated that GHAP is identical to the hyaluronatebinding region of a large fibroblast proteoglycan, versican [4] . Versican has been isolated recently from human brain [5] and was found in the precartilaginous mesenchyma during early development and post-natally in the brain [6, 7] . At least four different alternative spliced forms of versican have been identified [8] [9] [10] and several more are predicted [11, 12] .
Matrix metalloproteinases (MMPs) require both zinc and calcium for activity and digest proteins of the extracellular matrix. Collagenase (MMPI), gelatinases A and B (MMP2 and MMP9) and stromelysin (MMP3) are the main metalloproteinases and have the capacity to digest collagen, gelatin, fibronectin and the components of the basement membrane [13, 14] . Collagenase, stromelysin, gelatinases and PUMP (MMP7) have also been reported to cleave aggrecan, the main hyaluronate-binding proteoglycan in cartilage [15] [16] [17] . In cartilage, it is likely that the hyaluronate-binding region remains attached to the hyaluronate in the matrix while the large chondroitin sulphate-bearing domain is degraded further and diffuses out into the synovial fluid. It has been shown that during maturation and aging, as well as in osteoarthritis, there is an accumulation of degradation products of aggrecan including the hyaluronate-binding region [18] [19] [20] .
GHAP is identical, at the amino acid level, to the hyaluronatebinding region of versican [3, 4] . It was therefore pertinent to address the question of the relationship between GHAP and versican. The hypothesis was raised that cleavage of versican by lated from human brain by affinity chromatography digest versican and give rise to a polypeptide with electrophoretic mobility identical to GHAP. Immunoblot analysis, peptide mapping and C-terminal amino acid sequencing indicate that the polypeptide generated by digestion with human brain gelatinases is identical to GHAP. We suggest that GHAP is a naturally occurring versican degradation product. metalloproteinases in the brain would produce GHAP as part of the physiological turnover ofthe matrix. Here we present evidence that GHAP is present in vivo and may be a product of metalloproteinase digestion of versican.
MATERIALS AND METHODS Materials
High-and low-molecular-mass markers, gelatin-Sepharose and Q-Sepharose fast flow were purchased from Pharmacia (Piscataway, NJ, U.S.A.). Goat anti-(mouse IgG) (heavy and light chain) biotin-conjugated and phosphatase avidinconjugated were obtained from Vector (Burlingame, CA, U.S.A.). Laminin, Dulbecco's modified Eagle's medium and fetal-calf serum were purchased from Life Technologies (Gaithersburg, MD, U.S.A.). Bovine gelatin and a protein assay kit were obtained from Bio-Rad (Hercules, CA, U.S.A.), bovine testicular hyaluronidase and ,8-casein from Sigma (St. Louis, MO, U.S.A.). Chondroitinase ABC and carboxypeptidase Y were purchased from Boehringer Mannheim, and poly(vinylidene difluoride) (PVDF) membranes (Immobilon) were from Millipore (Bedford, MA, U.S.A.). All other chemicals were of analytical grade and purchased from Sigma.
Proteins
Monoclonal antibodies (mAbs) 6F7, 12C5 and 12D6 and rabbit antisera raised against GHAP and versican isolated from human brain have been described previously [3, 5, 21] . Human brain versican and GHAP were prepared as described earlier in the presence of protease inhibitors [3, 5] . Human brain versican was 1 mM iodoacetic acid. The homogenate was centrifuged at 20000 g for 10 min, the pellet was washed once and the final pellet was resuspended in the same buffer containing 25 mg of testicular hyaluronidase (1200 turbidity reducing units per mg). The mixture was incubated for 3 h at 37°C and centrifuged at 20000 g for 10 min. The supernatant was adjusted to 6 M urea and subjected to anion-exchange chromatography followed by gel-filtration chromatography [5] .
Recombinant human procollagenase and prostromelysin were expressed as described previously [22, 23] . The enzymes were purified using a combination of ion-exchange and dye-matrix chromatography. Human stromelysin [24] from articular cartilage was kindly provided by Dr. H. Nagase (University of Kansas). Mouse gelatinase was prepared from 3T3 mouse fibroblasts cultured in 10 % fetal bovine serum in Dulbecco's modified Eagle's medium at 37°C in an atmosphere of 5 % CO2 and 100 % humidity. The culture medium was removed, the flask washed twice with medium without serum and the cells were further cultured in Dulbecco's modified Eagle's medium without serum. After 3 days the medium was removed, centrifuged at 10000 g for 10 min at 2°C to remove any debris and the supernatant was applied to a gelatin-Sepharose column (10 ml) at a 10 ml/h flow rate. The column was washed with 200 ml of 10 mM Tris acetate, pH 7.6, containing 10 mM CaC12 and 1 M NaCl and bound gelatinase was eluted with the same buffer containing 5 % DMSO. Human brain gelatinases were prepared from brain removed during autopsy (12-18 h after death); 50 g of human brain was homogenized in 150 ml of 10 mM Tris acetate, pH 7.6, in the presence of 10 mM CaCl2 to stabilize the metalloproteinases and 1 mM PMSF, 1 ug/ml pepstatin and 1 mM iodoacetic acid as inhibitors. The homogenate was centrifuged at 20000 g for 10 min and the supernatant was applied to a Q-Sepharose fast flow column (2 cm x 10 cm) at a 50 ml/h flow rate. The column was washed with 100 ml of 10 mM Tris acetate, pH 7.6, followed by 100 ml of 250 mM NaCl/10 mM CaCl2 in 10 mM Tris acetate, pH 7.6. The 250 mM NaCl eluant was diluted with an equal volume of 10 mM Tris acetate, pH 7.6, 10 mM CaC12 and was run through a 10 ml gelatin-Sepharose column. The column was washed with 200 ml of 10 mM Tris acetate, pH 7.6, containing 10 mM CaCl2 and 1 M NaCl and bound metalloproteinases were eluted with the same buffer containing 5 % DMSO.
Reduction and aikylaton
Proteins were dissolved at a concentration of 1 mg/ml in 0.4 M Tris/HCI, pH 8.5, containing 6 M guanidine HCI, 2 mM EDTA and 3 mM dithiothreitol. The solution was purged with N2 and incubated at 37°C for 60 min. One-tenth volume of 200 mM iodoacetic acid (final concentration 20 mM) was added, the pH was adjusted to 7 with NaOH and further incubated for I h at 37°C in the dark.
Analytical procedures
Protein determination was performed using BSA as a standard, either by measuring the absorption at 280 nm or at 595 nm using the Bio-Rad protein determination kit [25] .
SDS/PAGE (4-15 % polyacrylamide) was carried out as described previously [26] with the omission of 2-mercaptoethanol unless noted. Staining was performed using 0. [27] . Immunoblots were performed as described [28] and reported earlier [5] . Occasionally the biotin-avidin phosphatase system from Vector was also used.
Zymograms employing 1 % (w/v) gelatin or 1 % (w/v) fl-casein in 9% and 11% SDS/PAGE, respectively, were performed by including these proteins in the polyacrylamide solution prior to polymerization [29] . Samples to be tested for their metalloproteinase activity were not heated and were not treated with 2-mercaptoethanol. The electrophoresis was carried out at 2°C and the gels were allowed to equilibrate for 4-5 h in 2.5 % Triton X-100 while shaking at 2°C (or 1 h at room temperature). The gels were then incubated in 20 mM Tris acetate, pH 7.6, 10 mM CaCl2 for 16 and 40 h (overnight or 2 days) at 37°C for detection of gelatinolytic and caseinolytic activity respectively.
Amino acid analysis and sequencing
Amino acid sequencing and in situ digestion with trypsin were performed as follows. Proteins separated by SDS/PAGE were transferred to PVDF as described [28] . Protein bands were stained with 0.1 % Ponceau S in 1 % acetic acid for 60 s followed by destaining with 1 % acetic acid. After several washes with water the bands of interest were cut out and subjected to amino acid analysis to determine the amount of protein transferred to the membrane.
For in situ digestion the PVDF membrane was cut into 1 mm x 2 mm pieces and placed in 100 ,ul of 10 % acetonitrile/1 % Triton X-100/100 mM Tris/HCI, pH 8.0/0.5 /eg of trypsin previously reduced and methylated to prevent autolytic digestion and treated with N-tosyl-L-phenylalanine chloromethyl ketone to remove any chymotrypsin-like activity (Promega, Madison, WI, U.S.A.). The incubation at 37°C was allowed to proceed for 24 h. The resulting peptide mixture was separated by narrowbore HPLC using a 2.1 mm x I50 mm Vydac C-18 reverse-phase column on a Hewlett-Packard 1090 HPLC with 1040 diode-array detector. Separation of the peptides was achieved using HPLC with a gradient of 5 to 90% acetonitrile in water with 0.06% trifluoroacetic acid over a period of 90 min. Optimum fractions were chosen based on symmetry, resolution and UV absorbance, and submitted to automated Edman degradation on 
RESULTS

GHAP and versican in bovine and human brain
We have previously reported that the monoclonal antibodies (mAbs) 6F7, 12C5 and 12D6, raised against GHAP [21] , do not react with versican on immunoblots [5] . We first determined whether GHAP and versican have the same electrophoretic mobility under reduced and non-reduced conditions. GHAP treated with reducing agents appears as a band with a molecular mass of 60 kDa [3] while GHAP not treated with reducing agents migrates as a band corresponding to a molecular mass of 53 kDa (Figure 1 ). Versican's electrophoretic mobility was unaffected by the presence or absence of 2-mercaptoethanol. The polyclonal antibody raised against GHAP [3] recognized GHAP and versican in immunoblots regardless of the treatment with reducing agents ( Figure 1 ). The 6F7 and 12C5 mAbs did not recognize versican under reduced conditions while they reacted with non-reduced versican. The mAbs also recognize the nonreduced GHAP better than the reduced GHAP ( Figure 1 ). Identical results were obtained using the 12D6 mAb raised against GHAP (results not shown). The 6F7 (Figure 1 ), 12C5 and 12D6 mAbs (results not shown) did not recognize at all reduced and alkylated GHAP and versican, suggesting that the antigenic epitopes are disulphide bond-dependent.
The GHAP preparation requires extraction under acidic conditions and three 30 min centrifugations in different pH and salt concentrations [3] . Therefore, there has been the suspicion that GHAP may not exist in vivo, but is rather a product of proteolytic digestion occurring during the preparation [31] . To address this question we first investigated whether human brain contains GHAP prior to the ac white matter (200 mg) obtained dL in 1 Isolated GHAP (G) (1 ,ug) and versican (V) (10 absence (-) of 2-mercaptoethanol using 4-1i stained with Coomassie Brilliant Blue followed phoretically transferred to PVDF [23] and subjecl and the 6F7 and the 12C5 mAbs raised against electrophoretic mobility corresponding to a lower-l GHAP (60 kDa). In SDS/PAGE, under reducing conditions, isolated bovine /tg) were separated in the presence (+) or GHAP appears as four bands at 76, 66, 54 and 52 kDa [32] . 5% SDS/PAGE. Proteins from the gels were Bovine brain was obtained from a local slaughterhouse. Small by silver staining (C.B.B./Silver) or electropieces (0.2-0.5 g) of brain white matter were frozen in liquid ted to immunoblotting with a rabbit antiserum GHAP. Note that non-reduced GHAP has an ntrogen within 15 mi of death and transported to the labmolecular-mass protein (53 kDa) than reduced oratory. The tissue was subjected to the short extraction and react with reduced GHAP as well as they react protease inhibitors, and immunoblot analysis was performed to determine the presence of versican and GHAP in these extracts (Figure 3 ). Versican and GHAP were present at the highest levels in cerebral white matter and only small amounts of versican were present in the human cerebral grey matter. This is in agreement with our immunohistochemical findings [3, 7] . Cerebellum and spinal cord also contained versican and GHAP; comparisons, however, of the amounts between these tissues are not warranted since the tissue from cerebellum and spinal cord contained both white and grey matter.
Metalloproteinase digestion of versican
Metalloproteinases digest aggrecan separating the hyaluronatebinding region from the chondroitin sulphate-rich region of the molecule. Collagenase (MMPl), gelatinases A and B (MMP2 and 9), stromelysin (MMP3) and PUMP (MMP7) have been reported to cleave the large hyaluronate-binding proteoglycan aggrecan [15] [16] [17] . We therefore hypothesized that GHAP may be the result of metalloproteinase digestion of versican. To test the hypothesis, versican was incubated with human recombinant stromelysin at 37°C in the presence of 10 mM CaCl2. After a 16 h period the proteoglycan was partially digested, shifting to a slightly lower molecular mass. At the same time a new band appeared with electrophoretic mobility identical to that ofGHAP (53 kDa under non-reduced conditions) (Figure 4a ). The antiserum raised against versican recognized all newly generated polypeptides. The 6F7 mAb, raised against GHAP, did not react with the large fragment but recognized the newly generated 53 kDa band (Figure 4a ). Amino acid sequencing ofa polypeptide derived after trypsin digestion of the 53 kDa band revealed the sequence LATVG, which corresponds to the 277-281 amino acid sequence of versican [4] . Human stromelysin from articular The reaction was stopped by boiling the mixture in SDS-sample buffer and proteins were subjected to 4-15% SDS/PAGE. Proteins were stained with Coomassie Brilliant Blue (58 ,ug of initial versican') or subjected to immunoblot with the 6F7 mAb (10 ug of initial versican'). G, human GHAP; M and M', high-and low-molecular-mass markers as in Figure 1 (Figure 4b ).
Isolation of human brain gelatinases
To determine whether brain contains any metalloproteinase activity which could digest versican, we used bovine and human brain, as well as rat spinal cord extracts. In all three cases, endogenous versican was completely digested after 24 h in the presence of 2 mM p-APMA, while no digestion was observed after incubation in the presence of EDTA which inhibits all metalloproteinases and other Ca2l-dependent proteinases (results not shown). Gelatinolytic activity in human and rat brain has been reported [33, 34] . In an effort to isolate the gelatinases present in the human brain, low-ionic-strength brain extracts (5) and human brain gelatinases (1 #zg) (HBG) were subjected to zymography in 1 % gelatin-and casein-containing gels. Gelatin-containing zymograms contained 9% polyacrylamide while casein-containing zymograms contained 11 % polyacrylamide to ensure immobilization of gelatin and casein respectively. Arrows point to the gelatinolytic and caseinolytic bands. The difference of the polyacrylamide content in the three gels accounts for the differences in the electrophoretic mobility of the human brain gelatinases.
were applied to a Q-Sepharose fast flow column, followed by affinity chromatography on gelatin-Sepharose as described in the Materials and methods section. The gelatinase activity was followed using gelatin-containing zymography. We observed all four gelatinases previously reported to exist in the human brain (approx. 70, 90, 130 and 250 kDa) [33, 35] Figure 5b ).
Digestion of versican with human brain gelatinases Versican isolated after extraction by hyaluronidase digestion of human brain was incubated with these gelatinases in the presence of 1 mM p-APMA and 10 mM CaCl2 for 20 h. Several polypeptides were observed by 4-15% SDS/PAGE followed by silver staining and a major band with the same molecular mass as GHAP (Figure 6 ). The newly generated polypeptide reacted with the 6F7 mAb raised against GHAP ( Figure 6 ). After prolonged incubation (72 h) of versican even the generated polypeptide was digested (results not shown). To determine if the versican preparation contains any (metallo-)proteinase activity, versican was incubated without human brain gelatinases in the presence of p-APMA and 10 mM CaCl2 (Figure 6 , V'a). To determine whether the preparation of human brain gelatinases can digest versican due to other proteinolytic activity, versican was incubated with human brain gelatinases without p-APMA ( Figure 6, V'c) . No (Figure 7) . The only qualitative difference is an additional peak in the tryptic map from the polypeptide obtained after versican digestion (arrowhead in Figure 7 ). The peptide was sequenced and found to belong to the hyaluronate-binding region of versican starting at the 17 1st amino acid (ACLDV). Quantitative differences between the chromatograms obtained at 210 nm are noted with arrows. The peak noted with the large arrow was sequenced and found to start at the 234th amino acid of versican, which is also part of the hyaluronate-binding region. The Figure 7 Peptide maps of naturally occurring and newly generated GIIA Samples (1 0 ug) of naturally occurring GHAP and the polypeptide generated after digestion of 80 ,sg of verSican' with human brain gelatinases (V'g) were electrophoresed in 4-15% SOS/PAGE transferred to PVDF and subjected to digestion with 0.5 4ug of trypsin. The mixtures were subjected to reverse-phase HPLC as described in the Materials and methods section. The elution of the various peptides was monitored at 210 nm and aromatic amino acid-containing peptides at 277 nm. Arrows point to quantitative differences between the two chromatograms, the arrowhead indicates a qualitative difference and asterisks point to peaks from both chromatograms that have been subjected to sequencing.
after each cycle of Edman degradation, suggesting that the peak from both chromatograms contained several additional polypeptides, which could account for the difference in absorption. Two peaks were sequenced and found to be identical starting at the 101st (VSVPT) and 289th (NGFDQ) amino acid of versican ( Figure 7 , asterisks from left to right). The chromatograms obtained at 277 nm (aromatic amino acids) were also similar with the only differences being the ones mentioned above (large arrow and arrowhead).
Edman degradation of the N-terminus of GHAP and the newly generated polypeptide after digestion of versican with the human brain gelatinases did not yield any amino acid sequence data. To determine the C-terminal sequence the following strategy was employed.. GHAP (10 ,sg) and the newly generated polypeptide were electrophoresed on 4-15 % SDS/PAGE, transferred to PVDF membranes and stained with Ponceau S. The membranes were incubated with 0.5 4ag of carboxypeptidase Y in 50 mM sodium citrate. Carboxypeptidase digests amino acids from the C-terminus. Amino acid analysis of the supernatants revealed that the main amino acid released -was Val, followed by Asx > Glx > Ala > Thr (Table 1) . This is consistent with the primary sequence of versican at the position 408EEEEECANATDV416. Gly is in the transfer buffer and was ignored. These results suggest that both GHAP and the newly generated polypeptide are identical in their respective C-termini, and that the cleavage occurs after the last cysteine of the hyaluronate-binding region of versican. Figure 8 ). The reactive band corresponding to versican and the four bands corresponding to the isolated bovine GHAP were scanned. Analysis using the NIH Image program indicated that there is an 80% increase of versican in the cerebral white matter and a 1060 % increase of Matrix metalloproteinases digest aggrecan, the major aggregating proteoglycan in articular cartilage, both in vitro and in vivo [15] [16] [17] 19, 20] . We hypothesized that versican may be susceptible to digestion by MMPs as well. Digestion with human recombinant collagenase, human recombinant stromelysin and mouse gelatinase A gave rise to a stable polypeptide with a molecular mass identical to GHAP. This polypeptide reacts with the antisera and mAbs raised against versican and GHAP.
There have been several reports in the literature on the secretion of metalloproteinases by brain tumours [35] , glioma [36] [37] [38] [39] [40] and neuronal [41] [42] [43] cell lines. It has also been shown that gelatinases are present in the human [33] and rat [34] brain. We isolated these gelatinases from human brain by means of anionic and affinity chromatography. We obtained highly enriched gelatinases which possess both gelatinolytic and caseinolytic activity. The preparation contains the 90, 130 and 230 kDa proteins reported earlier [33] . Two additional bands at 58 and 190 kDa were present on silver-stained gels but did not possess any caseinolytic or gelatinolytic activity.
The enriched metalloproteinase preparation was used for digestion of versican. Similarly to the other metalloproteinases tested, the human brain gelatinases gave rise to a polypeptide with molecular mass identical to that of GHAP, which reacts with antibodies raised against GHAP (Figures 4 and 6) . Digestion of GHAP and the newly generated polypeptide with trypsin revealed identical peptide maps (Figure 7) , and C-terminal sequencing suggested that the two polypeptides have identical Ctermini. We conclude thus that the newly generated polypeptide is identical to GHAP. We suggest that GHAP is an in vivo product of versican degradation in the brain.
The C-t-erminal sequence of GHAP and the newly generated GHAP indicates that the human brain gelatinases cleave versican at the 416VT417 position. Although this position has not been predicted to be a preferred one for metalloproteinase digestion [44] , we obtained results suggesting it as the site of cleavage. The physiological degradation of aggrecan has been reported with respect to articular cartilage. The hyaluronate-binding region is found in adult but not in newborn human cartilage and competes for binding to hyaluronate [18] , while the large chondroitin sulphate-containing fragment is further digested and diffuses into the synovial-joint space. Similarly, hyaluronate-binding fragments have been found in increased amounts in cartilage of aging individuals [45] . Increased concentrations of metalloproteinases have been found in cartilage from patients with rheumatoid arthritis and osteoarthritis [46] . Versican bound to hyaluronate creates a network surrounding certain neurons and myelinated axons in the CNS. Neurocan in the developing rat [47] and the Cat-301 chondroitin sulphate proteoglycan in the grey matter [48] may also participate in this network, which may serve the following functions. It has been suggested that extracellular matrix specifically binds to growth factors to increase their concentration locally [49] . The proteoglycans with the highly charged chondroitin sulphate chains may regulate ion transport between cells. A mechanical function is also envisaged. and the presence of GHAP could be due to autolysis. We. Immunofluorescence images of cryostat sections with antibodies 384 G. Perides and others against versican give the impression of barbed wire surrounding the myelinated axons and the large motor neurons providing a scaffold on which the neurons are stabilized. Degradation of the network may cause growth factor depletion, abnormalities in ion and small molecule supply, or destabilization of neuronal positioning. While at the initial stages the degradation of the extracellular matrix does not pose a problem, as it progresses it may cause heavy loss of neurons and have deleterious effects leading to dementia. Here we present evidence that in adult bovine brain there is an increased ratio of GHAP to versican compared with calf brain. In fact, we have recently reported that there is increased immunostaining of GHAP in the cerebral cortex of Alzheimer's patients and we suggested a role for matrix metalloproteinases in senile dementia [50] . We are presently investigating whether there are significant differences in the versican and GHAP content ofyoung, healthy old, and demented individuals.
Versican is a major component of the extracellular matrix of the CNS (approx. 20 mg of versican per 100 g of tissue). GHAP has been found to be non-permissive for neuronal growth [51] . GHAP and versican are expressed very late in development, i.e. post-natally and after the onset of myelination, in dog [52] , rat [6] and mouse [7] brain. Gliomas are notorious for their invasiveness. Brain tumours [35] and glioma cell lines secrete stromelysin and gelatinases [36] [37] [38] [39] [40] . Thus far no substrate has been determined for these metalloproteinases in the adult CNS except in the connective tissue forming blood vessels and the meninges. Spreading of the C6 glioma cells on CNS myelin or optic nerve explants was inhibited by 1,10-phenanthroline, a metalloproteinase inhibitor [46] . It has been suggested that the myelinbound inhibitory proteins may be substrates for metalloproteinase activity during glioblastoma infiltration of the CNS [53] . We suggest that gliomas secrete high levels of MMPs which digest versican, paving the way for the invasion of the tissue by the tumour cells.
